Cidara Therapeutics, Inc.
CDTX
Peringkat dalam Saham
#3187
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Harga Saham
$221.38
Terakhir disinkronkan: 2026-01-08
Kapitalisasi Pasar
$5.61B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
118.07%
Negara
US
Perdagangan Cidara Therapeutics, Inc. (CDTX)
Kategori
Healthcare
Rasio P/S untuk Cidara Therapeutics, Inc. (CDTX)
Rasio P/S per October 2026 TTM: 0.00
Menurut laporan keuangan dan harga saham terbaru dari Cidara Therapeutics, Inc., rasio P/S saat ini (TTM) adalah 0.00. Pada akhir 2023, rasio P/S perusahaan adalah 1.09.
Riwayat rasio P/S untuk Cidara Therapeutics, Inc. dari 2012 hingga 2026
Rasio P/S pada akhir setiap tahun
| Tahun | Rasio P/S | Mengubah |
|---|---|---|
| 2026 (TTM) | 0.00 | -100.00% |
| 2024 | 133.87 | 12,223.04% |
| 2023 | 1.09 | 32.15% |
| 2022 | 0.82 | -38.80% |
| 2021 | 1.34 | -80.50% |
| 2020 | 6.89 | 25.32% |
| 2019 | 5.50 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
| 2012 | 0.00 | 0.00% |
Rasio P/S untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/S | Perbedaan Rasio P/S | Negara |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
